83P Impact of treatment duration of extended adjuvant therapy with neratinib in early stage HER2+ HR+ breast cancer after trastuzumab-based therapy on patient outcomes
Titel:
83P Impact of treatment duration of extended adjuvant therapy with neratinib in early stage HER2+ HR+ breast cancer after trastuzumab-based therapy on patient outcomes
Auteur:
Martin Jimenez, M. Gnant, M.I. Ejlertsen, B. Mansi, J.L. Ruiz-Borrego, M. Jakobsen, E.H. Osborne, C.K. Birhiray, R. Zhang, B. Wong, A. Moy, B. Holmes, F.A.